Blood stem cell grafts: frozen is fine, but fresh is best
- PMID: 37815816
- PMCID: PMC10580167
- DOI: 10.1182/bloodadvances.2023010372
Blood stem cell grafts: frozen is fine, but fresh is best
Conflict of interest statement
Comment on
-
Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemic.Blood Adv. 2023 Oct 10;7(19):5982-5993. doi: 10.1182/bloodadvances.2023009786. Blood Adv. 2023. PMID: 37036959 Free PMC article.
References
-
- Auletta JJ, Novakovich JL, Stritesky GL, et al. Meeting the demand for unrelated donors in the midst of the COVID-19 pandemic: rapid adaptations by the national marrow donor program and its network partners ensured a safe supply of donor products. Transplant Cell Ther. 2021;27(2):133–141. - PMC - PubMed
-
- Marti F, Miralles A, Peiro M, et al. Differential effect of cryopreservation on natural killer cell and lymphokine-activated killer cell activities. Transfusion. 1993;33(8):651–655. - PubMed
-
- Schafer AK, Waterhouse M, Follo M, et al. Phenotypical and functional analysis of donor lymphocyte infusion products after long-term cryopreservation. Transfus Apher Sci. 2020;59(1) - PubMed
-
- Worsham DN, Reems JA, Szczepiorkowski ZM, et al. Clinical methods of cryopreservation for donor lymphocyte infusions vary in their ability to preserve functional T-cell subpopulations. Transfusion. 2017;57(6):1555–1565. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
